Location · Palo Alto, CA
Clinical trials in Palo Alto, CA
125 recruiting studies have a site in Palo Alto, and 45 of them accept healthy volunteers.
125 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC
- Location
- Palo Alto, CA + 50 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
SoniVie Inc.
- Location
- Palo Alto, CA + 33 other US sites
- Eligibility basics
- Ages 22–75
- RecruitingPhase 1
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Insmed Gene Therapy LLC
- Location
- Palo Alto, CA + 6 other US sites
- Eligibility basics
- Ages 18–79
- Recruiting
TVMR With the INNOVALVE System Trial - Early Feasibility Study
Edwards Lifesciences
- Location
- Palo Alto, CA + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Novo Nordisk A/S
- Location
- Palo Alto, CA + 42 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 1/Phase 2
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
NaviFUS Corporation
- Location
- Palo Alto, CA + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- Palo Alto, CA + 65 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Vega Therapeutics, Inc
- Location
- Palo Alto, CA + 13 other US sites
- Eligibility basics
- Ages 12–75
- RecruitingPhase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Sarepta Therapeutics, Inc.
- Location
- Palo Alto, CA + 10 other US sites
- Eligibility basics
- Ages 2+ · Men only
- RecruitingPhase 1/Phase 2
Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J)
Elpida Therapeutics SPC
- Location
- Palo Alto, CA
- Eligibility basics
- Ages 3–20
- RecruitingPhase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Astellas Institute for Regenerative Medicine
- Location
- Palo Alto, CA + 12 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 1
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
Biogen
- Location
- Palo Alto, CA + 11 other US sites
- Eligibility basics
- Ages 3+
- RecruitingPhase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Merck Sharp & Dohme LLC
- Location
- Palo Alto, CA + 19 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 1/Phase 2
ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
Alexion Pharmaceuticals, Inc.
- Location
- Palo Alto, CA + 6 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
Relay Therapeutics, Inc.
- Location
- Palo Alto, CA + 21 other US sites
- Eligibility basics
- Ages 2+
- Recruiting
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
MMI (Medical Microinstruments, Inc.)
- Location
- Palo Alto, CA + 2 other US sites
- Eligibility basics
- Ages 50+
- Recruiting
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Alcyone Therapeutics, Inc
- Location
- Palo Alto, CA + 14 other US sites
- Eligibility basics
- Ages 3+
- RecruitingPhase 2
A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
BioMendics, LLC
- Location
- Palo Alto, CA + 1 other US site
- Eligibility basics
- Ages 2+
- Recruiting
BOOM-IBD2 Pivotal Clinical Trial
Boomerang Medical
- Location
- Palo Alto, CA + 15 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
AbbVie
- Location
- Palo Alto, CA + 14 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
- Location
- Palo Alto, CA + 33 other US sites
- Eligibility basics
- Ages 45–75
- RecruitingPhase 2/Phase 3
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Palo Alto, CA + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2/Phase 3
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Kyverna Therapeutics
- Location
- Palo Alto, CA + 9 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Healx Limited
- Location
- Palo Alto, CA + 13 other US sites
- Eligibility basics
- Ages 12+